Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Moreira Folegatti P"'
Autor:
Hannah R. Sharpe, Nicholas M. Provine, Georgina S. Bowyer, Pedro Moreira Folegatti, Sandra Belij-Rammerstorfer, Amy Flaxman, Rebecca Makinson, Adrian V.S. Hill, Katie J. Ewer, Andrew J. Pollard, Paul Klenerman, Sarah Gilbert, Teresa Lambe
Publikováno v:
JCI Insight, Vol 7, Iss 6 (2022)
Cytomegalovirus (CMV) is a globally ubiquitous pathogen with a seroprevalence of approximately 50% in the United Kingdom. CMV infection induces expansion of immunosenescent T cell and NK cell populations, with these cells demonstrating lower responsi
Externí odkaz:
https://doaj.org/article/e4a4682673c846b98452e03a01c6e769
Autor:
Moreira Folegatti, P
Traditional vaccine development strategies are costly and time-consuming which makes them unsuitable for clinical assessment of new vaccines in the context of infectious diseases outbreaks. Platform technologies provide substantial manufacturing adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::4ffce40837b2834e3e47d02e119ab013
https://ora.ox.ac.uk/objects/uuid:5db30362-688a-4a9e-af70-ca6e76f2c26c
https://ora.ox.ac.uk/objects/uuid:5db30362-688a-4a9e-af70-ca6e76f2c26c
Autor:
José Angelo Lauletta Lindoso, Carlos Henrique Valente Moreira, Beatriz Julieta Celeste, Luiza Keiko Matsuka Oyafuso, Pedro Moreira Folegatti, Eduard Evert Zijlstra
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 51, Iss 1, Pp 105-107
Abstract Visceral leishmaniasis is common in Brazil and is caused by Leishmania (Leishmania) infantum/chagasi. Post-kala-azar dermal leishmaniasis frequently follows visceral leishmaniasis caused by L. donovani, and para-kala-azar dermal leishmaniasi
Externí odkaz:
https://doaj.org/article/51dfe9f0dddc44febfe4b8319b74f467
Autor:
Sharpe HR; Jenner Institute and., Provine NM; Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, United Kingdom., Bowyer GS; Jenner Institute and., Moreira Folegatti P; Jenner Institute and., Belij-Rammerstorfer S; Jenner Institute and., Flaxman A; Jenner Institute and., Makinson R; Jenner Institute and., Hill AV; Jenner Institute and., Ewer KJ; Jenner Institute and., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom., Klenerman P; Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, United Kingdom., Gilbert S; Jenner Institute and., Lambe T; Jenner Institute and.; Oxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, United Kingdom.
Publikováno v:
JCI insight [JCI Insight] 2022 Mar 22; Vol. 7 (6). Date of Electronic Publication: 2022 Mar 22.